Status:
Awaiting development
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:

The Topic Selection Oversight Panel (TSOP) met on 01 July 2020 and agreed that this topic should proceed to guidance development. 

Process:
STA Standard
ID number:
3771

Timeline

Key events during the development of the guidance:

Date Update
01 July 2020 Awaiting development. Status change linked to topic prioritisation decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual